Showing Results : 1-1 of 1
Sort By :


Therapeutic Advances in Drug Safety

Published By SAGE Publishing

  • Therapeutic Advances in Drug Safety: 2023, vol: 14, issue:
  • 1)- Nokuthula L Makhene, Hanlie Steyn, Martine Vorster, Martie S Lubbe, Johanita R Burger. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review. Therapeutic advances in drug safety. 2023, 14: 20420986221143272
    Cited : 2
    Read More
  • 2)- Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Jane Louisa Debus, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl. Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy. Therapeutic advances in drug safety. 2023, 14: 20420986221143830
    Cited : 4
    Read More
  • 3)- Fiona Robinson, Sonji Wilkes, Nathan Schaefer, Miriam Goldstein, Michelle Rice, Johanna Gray, Sharon Meyers, Leonard A Valentino. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community. Therapeutic advances in drug safety. 2023, 14: 20420986221146418
    Cited : 4
    Read More
  • 4)- Ning Qin, Yinglong Duan, Shuangjiao Shi, Xiao Li, Haoqi Liu, Feng Zheng, Zhuqing Zhong, Guliang Xiang. Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS). Therapeutic advances in drug safety. 2023, 14: 20420986231152934
    Cited : 0
    Read More
  • 5)- Ali F Altebainawi, Lulwa A Alfaraj, Amjad A Alharbi, Fadwa F Alkhuraisi, Thamir M Alshammari. Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database. Therapeutic advances in drug safety. 2023, 14: 20420986231154075
    Cited : 9
    Read More
  • 6)- Fatema A Alqenae, Douglas Steinke, Andrew Carson-Stevens, Richard N Keers. Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study. Therapeutic advances in drug safety. 2023, 14: 20420986231154365
    Cited : 8
    Read More
  • 7)- Charlotte Arp Sørensen, Linda Jeffery, Jannik Falhof, Philipp Harbig, Klaus Roelsgaard, Solveig Gram, Charlotte Olesen. Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice. Therapeutic advances in drug safety. 2023, 14: 20420986231159221
    Cited : 2
    Read More
  • 8)- Heyde-Patricia Zuluaga-Arias, Mayada Alkhakany, Manal M Younus, Houda Sefiani, Angela Caro-Rojas, Sameh Al-Zubiedi, Wafi F Albalawi, Thamir M Alshammari. Impact of risk communication on patient's safety during the pandemic. Therapeutic advances in drug safety. 2023, 14: 20420986231159752
    Cited : 4
    Read More
  • 9)- Sara Eslait-Olaciregui, Kevin Llinás-Caballero, David Patiño-Manjarrés, Thomas Urbina-Ariza, Juan Fernando Cediel-Becerra, Camilo Alberto Domínguez-Domínguez. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature. Therapeutic advances in drug safety. 2023, 14: 20420986231165674
    Cited : 2
    Read More
  • 10)- Yang Lu, Caiyun Guo. Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients. Therapeutic advances in drug safety. 2023, 14: 20420986231178126
    Cited : 5
    Read More
  • 11)- Britney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, Matthew P Gray, Richard D Boyce, Sandra L Kane-Gill. Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study. Therapeutic advances in drug safety. 2023, 14: 20420986231181334
    Cited : 5
    Read More
  • 12)- Chang Liu, Qianqian Zhang, Peiye Hui, Yan Wang, Guohui Li, Guangchao Cao, Zicheng Xue, Jing Zhang, Heng Zhang, Xin Huang, Jiyong Wu, Fusehng Sun, Meixing Yan. Safety monitoring of oral iron supplements in pregnant women with anemia: a multi-center observational clinical study. Therapeutic advances in drug safety. 2023, 14: 20420986231181335
    Cited : 0
    Read More
  • 13)- Ivana Damnjanović, Nastia Tsyplakova, Nikola Stefanović, Tatjana Tošić, Aleksandra Catić-Đorđević, Vangelis Karalis. Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population. Therapeutic advances in drug safety. 2023, 14: 20420986231181337
    Cited : 4
    Read More
  • 14)- Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour. Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study. Therapeutic advances in drug safety. 2023, 14: 20420986231181338
    Cited : 3
    Read More
  • 15)- Opeyemi Atanda, Jonathan West, Tom Stables, Chris Johnson, Robert Merrifield, James Kinross. Flow rate accuracy of infusion devices within healthcare settings: a systematic review. Therapeutic advances in drug safety. 2023, 14: 20420986231188602
    Cited : 3
    Read More
  • 16)- Ambrose O Isah, Abimbola O Opadeyi, Henry Tumwijukye, Frank Cobelens, Diede Smith, Margareth Ndomondo-Sigonda, Linda Harmark, Paul Tanui, Edine Tiemersma, Blandina T Mmbaga, Gugu Mahlangu, Stephen A Ayinbuomwan, Rachida Soulaymani, Jayesh M Pandit. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries. Therapeutic advances in drug safety. 2023, 14: 20420986231188836
    Cited : 1
    Read More
  • 17)- Lillian Asio, Marble Nasasira, Ronald Kiguba. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors. Therapeutic advances in drug safety. 2023, 14: 20420986231188842
    Cited : 1
    Read More
  • 18)- Florian Schindler, Timo Schinkoethe, Sven Mahner, Thomas Kolben, Rachel Wuerstlein, Carsten Culmsee, Nadia Harbeck, Tanja K Eggersmann. Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers. Therapeutic advances in drug safety. 2023, 14: 20420986231188845
    Cited : 2
    Read More
  • 19)- Zenebe Negash, Yohannes Yibeltal, Akeberegn Gorems Ayele. HIV/AIDS patients' knowledge, attitude, and practice toward anti-retroviral therapy medications' adverse effects and associated factors in Tikur Anbessa Specialized Hospital. Therapeutic advances in drug safety. 2023, 14: 20420986231194752
    Cited : 0
    Read More
  • 20)- Carlos-Alberto Calderon-Ospina. Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance. Therapeutic advances in drug safety. 2023, 14: 20420986231194754
    Cited : 0
    Read More
  • 21)- Yanping Li, Yuanlin Wu, Tingting Jiang, Haiyan Xing, Jing Xu, Chen Li, Rui Ni, Ni Zhang, Guiyuan Xiang, Li Li, Ziwei Li, Lanlan Gan, Yao Liu. Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature. Therapeutic advances in drug safety. 2023, 14: 20420986231200746
    Cited : 3
    Read More
  • 22)- Winter Roth, David Dadiomov, Michelle Chu. Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects. Therapeutic advances in drug safety. 2023, 14: 20420986231213173
    Cited : 0
    Read More
  • 23)- Yodit Fitsum, Azania Werede, Abubeker Mahmud Saleh, Eyasu H Tesfamariam, Francis Magombo, Freminatos Misghina, Hermella Yemane, Iyassu Bahta, Liya Abraham, Merhawi Bahta, Merhawi Debesai, Meron Tesfagaber, Michael Ghirmai, Sirak Tesfamariam, Mulugeta Russom. Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey. Therapeutic advances in drug safety. 2023, 14: 20420986231213713
    Cited : 0
    Read More
  • 24)- Charlotte Arp Sørensen, Linda Jeffery, Klaus Roelsgaard, Solveig Gram, Jannik Falhof, Philipp Harbig, Charlotte Olesen. Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study. Therapeutic advances in drug safety. 2023, 14: 20420986231213714
    Cited : 0
    Read More
  • 25)- Chenyang Xu, Rui Peng, Xiali Qian, Shanwu Feng, Hongmei Yuan. Modified Dixon sequential method to determine the effective dose of alfentanil compounded with propofol for day-case hysteroscopy. Therapeutic advances in drug safety. 2023, 14: 20420986231214992
    Cited : 2
    Read More
 
 


Journal List
Links
Content Links
About Us

4 ....